Clinical Trial Update: Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PET tracers 68Ga-PSMA-11 vs 18F-Fluorocholine for prostate cancer recurrence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Prostate Cancer | Phase 3 | Status: UNKNOWN